Search

Author/Creator Garg, Pushkal

1. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study. Issue 4 (22nd January 2019)

Authors:
Solomon, Scott D.; Adams, David; Kristen, Arnt; Grogan, Martha; González-Duarte, Alejandra; Maurer, Mathew S.; Merlini, Giampaolo; Damy, Thibaud; Slama, Michel S.; Brannagan, Thomas H.; Dispenzieri, Angela; Berk, John L.; Shah, Amil M.; Garg, Pushkal; Vaishnaw, Akshay; Karsten, Verena; Chen, Jiho...
Journal:
Circulation
Issue:
Volume 139:Issue 4(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. LB002ILLUMINATE-A, A PHASE 3 STUDY OF LUMASIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC, IN CHILDREN AND ADULTS WITH PRIMARY HYPEROXALURIA TYPE 1 (PH1). (7th June 2020)

Authors:
Garrelfs, Sander; Frishberg, Yaacov; Hulton, Sally; Koren, Michael; O'Riordan, William; Cochat, Pierre; Deschenes, Georges; Shasha-Lavsky, Hadas; Saland, Jeffrey; Van't Hoff, William; Fuster, Daniel Guido; Magen, Daniella; Moochhala, Shabbir; Schalk, Gesa; Simkova, Eva; Groothoff, Jaap; Sas, Davi...
Journal:
Nephrology dialysis transplantation
Issue:
Volume 35(2020)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects. Issue 2 (13th August 2020)

Authors:
Habtemariam, Bahru A.; Karsten, Verena; Attarwala, Husain; Goel, Varun; Melch, Megan; Clausen, Valerie A.; Garg, Pushkal; Vaishnaw, Akshay K.; Sweetser, Marianne T.; Robbie, Gabriel J.; Vest, John
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 109:Issue 2(2021)
Page Start:
372
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗